Skip to main content
. 2017 Apr 10;5:68. doi: 10.3389/fped.2017.00068

Table 1.

Pediatric venous thromboembolism risk-assessment models.

Branchford et al. (36) Sharathkumar et al. (27) Arlikar et al. (23) Atchison et al. (49) Reiter et al. (52)a Kerlin et al. (50, 53)
Pediatric population All All ICU Non-ICU ICU All
Study design for score derivation Retrospective case–control (1:2) Retrospective case–control (1:2) Retrospective case–control (1:3) Retrospective case–control (1:7) Literature review Retrospective cohort
N 78:160 173:346 57:171 50:350 389
Validation method Retrospective case–control (1:1) Prospective, observational cohort study Retrospective cohort
N 100:100 742 149
Risk factors comprising score MV
Infection
LOS ≥ 5 days
Immobilization CVC
LOS ≥ 4 days
Infection
CVC
Infection
LOS ≥ 4 days
CVC Male gender
LOS ≥ 7 days Immobility >72 h Asymmetric extremity
OCP Infection CVC
CVC Orthopedic surgery Active cancer
Bacteremia Major trauma (ISS > 15) Alternative diagnosisb
Direct ICU admit Malignancy
OCP
Burns >30% BSA
Thrombophilia
Age <1 or >14 years
Obesity
Hypercoagulable state

ICU, intensive care unit; MV, mechanical ventilation; LOS, length of stay; OCP, oral contraceptive pill; CVC, central venous catheters; ISS, injury severity score; BSA, body surface area.

aIncluded venous and arterial thromboembolism in their study.

bPresence of this factor results in point reduction from score.